SCHEMBL31072018

SCHEMBL31072018

CCOC(=O)C(F)(F)CCC(=O)c1ccc(F)cc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2R P25116 1/20 0.40
MAPT P10636 5/20 0.39
NPSR1 Q6W5P4 3/20 0.39
LMNA P02545 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 2/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
FBP1 P09467 1/20 0.36
PKM P14618 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 2/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21767653 1.00 F2R (0.40) F2RMAPTNPSR1LMNACYP1A2
SCHEMBL21780541 0.88 F2R (0.39) F2RMAPTNPSR1LMNACYP1A2
SCHEMBL26044824 0.82 F2R (0.41) F2RMAPTPKMTHRATHRB
SCHEMBL21858005 0.80 F2R (0.40) F2RMAPTNPSR1LMNACYP1A2
SCHEMBL29622995 0.80 F2R (0.40) F2RMAPTNPSR1LMNACYP1A2
SCHEMBL21784777 0.80 F2R (0.39) F2RMAPTNPSR1LMNACYP1A2
SCHEMBL22118404 0.78 HTR7 (0.53) MAPTNPSR1LMNACYP1A2CYP2C9
SCHEMBL21857985 0.78 F2R (0.41) F2RMAPTNPSR1LMNACYP1A2
SCHEMBL21780538 0.77 F2R (0.56) F2RMAPTNPSR1LMNAMEN1
SCHEMBL21857955 0.77 F2R (0.44) F2RMAPTNPSR1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118878533-A Inhibition of αvβ6 integrin 莫菲克医疗股份有限公司 2024-11-01 CN disclosed
CN-112805001-B Inhibition of αvβ6 integrin 莫菲克医疗股份有限公司 2024-07-23 CN disclosed